I wonder if it’s a thing where it’s taking a while for those things to hit. Like, mRNA vaccines are only a couple of years old, GLP-1RAs are in a gradual process of being rolled out, etc. If I think of the category of “awesome newish bio stuff I’d like to use”, it seems like most of it becomes widely available to consumers in the near future or last 5 years, with the exception of statins.
Right, I think bio stuff is slower and involves somewhat deeper science. (Compared to car manufacturing, in some sense, maybe. Though it’s hard to say / unclear what the question is, because you have deep stuff with chip manufacturing, and special alloys, and so on; but I think bio has much more prerequisite scientific richness to its big advances). Because it’s slower and deeper, it’s more opaque (i.e. harder to do credit assignment).
I think it’s not just that it’s slower/deeper: my personal sense (which might be just a thing of not requiring much medical care between the ages of 5 and 30) is that the pace at which awesome new stuff is happening in medicines I can buy got much faster in the last few years. If my perception is right, it seems like that requires some explanation of “bio is slower/deeper and also 40 years ago there was a massive breakthru that took 40 years to percolate”, and not just “bio is slower/deeper”.
Well, to really evaluate this I’d want to see some sort of thorough-ish investigation, that tries to think of most of the main ways that bio would have been impacting people’s lives, and checking the timescales for the prerequisite research. It’s not something I’d update very much about, based on anecdata, because it’s too big of a question.
Drug approvals have gone up in recent years: https://pmc.ncbi.nlm.nih.gov/articles/PMC10856271/ (figure 1). Of course most of those are not ones that you’ll encounter in day-to-day life. Meanwhile, some of the most commonly used over-the-counter drugs from previous decades have been pulled from the market or made harder to get (cold medicine particularly: phenylpropanolamine due to rare side effects in 2000, oral phenylephrine due to lack of effect last year, and pseudoephedrine restricted to behind the counter due to use in meth a decade ago or so).
My guess is that the big difference in the speed of biotech compared to early-20th-century-advancements is the relative conservatism of the medical field, and the money & time-consuming certifications you need to get before releasing anything to market. This, in my view, is much less a function of the science, and much more a function of the sociology around the science.
I imagine that’s one relevant thing going on, but also I think the actual science has a lot more depth. The progress I listed doesn’t seem like it’s going slower due to medical regulation.
The progress I listed doesn’t seem like it’s going slower due to medical regulation.
I mean the basic research aspect sure (except for stem cells), but applications of each of the progress areas you listed basically involve either clinical applications or selling GMOs. Both of which have very bad regulatory bottlenecks, especially from a world-wide perspective.
There has been, as you mention, enormous progress in bio-tech and our broader understanding of biology in the past 50 years, but comparatively little application of that knowledge. This is not what you would expect if the science is “deep” but applications easy. How exactly does the progress you listed support this conclusion?
Yeah, as I mentioned in my earlier comment bio stuff is:
inherently slower (slow experiments, more caution, more regulation, more difficult problems)
So yeah I agree applications are also difficult. One thing I’m trying to say is “the progress of bio feels slower in significant part because the science itself is difficult, and is actually slower in a sense, but this is a confusing way to view it because there has also been a large amount of scientific progress; so it’s slower in some sense of being less progress per time relative to the total difficulty of the field, i.e. we’re still mostly confused and mostly powerless in the domain of bio; but the absolute quantity of knowledge and power we’ve gained is large; but people don’t appreciate that; partly that’s because the applications are separately harder and slower, and maybe partly that’s because it’s harder / less legible to attribute the applications to the font of deep progress”.
I wonder if it’s a thing where it’s taking a while for those things to hit. Like, mRNA vaccines are only a couple of years old, GLP-1RAs are in a gradual process of being rolled out, etc. If I think of the category of “awesome newish bio stuff I’d like to use”, it seems like most of it becomes widely available to consumers in the near future or last 5 years, with the exception of statins.
Right, I think bio stuff is slower and involves somewhat deeper science. (Compared to car manufacturing, in some sense, maybe. Though it’s hard to say / unclear what the question is, because you have deep stuff with chip manufacturing, and special alloys, and so on; but I think bio has much more prerequisite scientific richness to its big advances). Because it’s slower and deeper, it’s more opaque (i.e. harder to do credit assignment).
I think it’s not just that it’s slower/deeper: my personal sense (which might be just a thing of not requiring much medical care between the ages of 5 and 30) is that the pace at which awesome new stuff is happening in medicines I can buy got much faster in the last few years. If my perception is right, it seems like that requires some explanation of “bio is slower/deeper and also 40 years ago there was a massive breakthru that took 40 years to percolate”, and not just “bio is slower/deeper”.
Well, to really evaluate this I’d want to see some sort of thorough-ish investigation, that tries to think of most of the main ways that bio would have been impacting people’s lives, and checking the timescales for the prerequisite research. It’s not something I’d update very much about, based on anecdata, because it’s too big of a question.
Drug approvals have gone up in recent years: https://pmc.ncbi.nlm.nih.gov/articles/PMC10856271/ (figure 1). Of course most of those are not ones that you’ll encounter in day-to-day life. Meanwhile, some of the most commonly used over-the-counter drugs from previous decades have been pulled from the market or made harder to get (cold medicine particularly: phenylpropanolamine due to rare side effects in 2000, oral phenylephrine due to lack of effect last year, and pseudoephedrine restricted to behind the counter due to use in meth a decade ago or so).
My guess is that the big difference in the speed of biotech compared to early-20th-century-advancements is the relative conservatism of the medical field, and the money & time-consuming certifications you need to get before releasing anything to market. This, in my view, is much less a function of the science, and much more a function of the sociology around the science.
I imagine that’s one relevant thing going on, but also I think the actual science has a lot more depth. The progress I listed doesn’t seem like it’s going slower due to medical regulation.
I mean the basic research aspect sure (except for stem cells), but applications of each of the progress areas you listed basically involve either clinical applications or selling GMOs. Both of which have very bad regulatory bottlenecks, especially from a world-wide perspective.
There has been, as you mention, enormous progress in bio-tech and our broader understanding of biology in the past 50 years, but comparatively little application of that knowledge. This is not what you would expect if the science is “deep” but applications easy. How exactly does the progress you listed support this conclusion?
Yeah, as I mentioned in my earlier comment bio stuff is:
So yeah I agree applications are also difficult. One thing I’m trying to say is “the progress of bio feels slower in significant part because the science itself is difficult, and is actually slower in a sense, but this is a confusing way to view it because there has also been a large amount of scientific progress; so it’s slower in some sense of being less progress per time relative to the total difficulty of the field, i.e. we’re still mostly confused and mostly powerless in the domain of bio; but the absolute quantity of knowledge and power we’ve gained is large; but people don’t appreciate that; partly that’s because the applications are separately harder and slower, and maybe partly that’s because it’s harder / less legible to attribute the applications to the font of deep progress”.